BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11722995)

  • 1. Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond.
    Sullivan KM; Dykewicz CA; Longworth DL; Boeckh M; Baden LR; Rubin RH; Sepkowitz KA; ; ;
    Hematology Am Soc Hematol Educ Program; 2001; ():392-421. PubMed ID: 11722995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients.
    Dykewicz CA; ; ;
    Clin Infect Dis; 2001 Jul; 33(2):139-44. PubMed ID: 11418871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
    ; ;
    Biol Blood Marrow Transplant; 2000; 6(6a):7-83. PubMed ID: 11185897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients.
    ; ;
    MMWR Recomm Rep; 2000 Oct; 49(RR-10):1-125, CE1-7. PubMed ID: 11718124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing opportunistic infections in bone marrow transplant recipients.
    Dykewicz CA
    Transpl Infect Dis; 1999 Mar; 1(1):40-9. PubMed ID: 11428970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations.
    Fraser GA; Walker II;
    Biol Blood Marrow Transplant; 2004 May; 10(5):287-97. PubMed ID: 15111928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral prophylaxis].
    Graubner UB
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A69-76. PubMed ID: 11577365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An international comparison of current strategies to prevent herpesvirus and fungal infections in hematopoietic cell transplant recipients.
    Pollack M; Heugel J; Xie H; Leisenring W; Storek J; Young JA; Kukreja M; Gress R; Tomblyn M; Boeckh M
    Biol Blood Marrow Transplant; 2011 May; 17(5):664-73. PubMed ID: 20699126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections.
    Dykewicz CA; ; ;
    Biol Blood Marrow Transplant; 2001; 7 Suppl():19S-22S. PubMed ID: 11777100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
    Mofenson LM; Brady MT; Danner SP; Dominguez KL; Hazra R; Handelsman E; Havens P; Nesheim S; Read JS; Serchuck L; Van Dyke R; ; ; ; ;
    MMWR Recomm Rep; 2009 Sep; 58(RR-11):1-166. PubMed ID: 19730409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, the Center for International Blood and Marrow Transplant Research, and the American Society of Blood and Marrow Transplantation.
    Rizzo JD; Wingard JR; Tichelli A; Lee SJ; Van Lint MT; Burns LJ; Davies SM; Ferrara JL; SociƩ G
    Biol Blood Marrow Transplant; 2006 Feb; 12(2):138-51. PubMed ID: 16443512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Boeckh M; Bowden RA; Storer B; Chao NJ; Spielberger R; Tierney DK; Gallez-Hawkins G; Cunningham T; Blume KG; Levitt D; Zaia JA
    Biol Blood Marrow Transplant; 2001; 7(6):343-51. PubMed ID: 11464977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Brissot E; Alsuliman T; Beauvais D; Bonnin A; Mear JB; Souchet L; Villate A; Yakoub-Agha I; Bazarbachi A
    Bull Cancer; 2020 Jan; 107(1S):S1-S6. PubMed ID: 31627903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccination].
    Graubner UB; Liese J; Belohradsky BH
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A77-83. PubMed ID: 11577366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital infection control in hematopoietic stem cell transplant recipients.
    Dykewicz CA
    Emerg Infect Dis; 2001; 7(2):263-7. PubMed ID: 11294720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New agents for the prevention of opportunistic infections in haematopoietic stem cell transplant recipients.
    Zuccotti G; Strasfeld L; Weinstock DM
    Expert Opin Pharmacother; 2005 Aug; 6(10):1669-79. PubMed ID: 16086653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.
    Crippa F; Holmberg L; Carter RA; Hooper H; Marr KA; Bensinger W; Chauncey T; Corey L; Boeckh M
    Biol Blood Marrow Transplant; 2002; 8(5):281-9. PubMed ID: 12064366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
    Burns LJ; Miller W; Kandaswamy C; DeFor TE; MacMillan ML; Van Burik JA; Weisdorf DJ
    Bone Marrow Transplant; 2002 Dec; 30(12):945-51. PubMed ID: 12476289
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.